scispace - formally typeset
M

Massimo Tommasino

Researcher at International Agency for Research on Cancer

Publications -  334
Citations -  14170

Massimo Tommasino is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Cancer & HPV infection. The author has an hindex of 62, co-authored 312 publications receiving 12239 citations. Previous affiliations of Massimo Tommasino include German Cancer Research Center & World Health Organization.

Papers
More filters
Journal Article

Functional studies of E7 proteins from different HPV types.

TL;DR: Although HPV1 E7 showed the same affinity in vitro and in vivo as the high risk HPV E7s, it did not have the ability to activate the E2F-1 transcription factor inhibited by Rb1, nor did it have any transforming activity when coexpressed with activated ras in primary rodent cells.
Journal ArticleDOI

The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies.

TL;DR: The data indicate that restriction of neutralization to HPV16 is due to sequence (or structural) differences laying outside of the epitope, and may pave the way to novel vaccination approaches specifically evoking cross-neutralizing antibody responses.
Journal ArticleDOI

TP53 mutations in squamous-cell carcinomas of the conjunctiva: evidence for UV-induced mutagenesis.

TL;DR: The results confirm at the molecular level the causal role of solar UV rays in the aetiology of squamous cell carcinoma of the conjunctiva and suggest that infection with epidermodysplasia verruciformis types of human papillomavirus may act as a cofactor to increase the sensitivity of conjunctivas cells to UV-induced mutagenesis.
Journal ArticleDOI

The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.

TL;DR: The findings suggest that the reported antagonistic roles of RhoA and Rac1 in cell motility/invasion and cytoskeletal organization may be due, in part, to their concerted action on NHE1 activity as a convergence point.